Clinical Trials Browser

Neoplasms × Diphenhydramine × Clear all

Neoplasms

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT00185692 2019-12-04

Allogeneic Transplantation From Related Haploidentical Donors

Phase 2 Completed

16 enrolled 8 charts

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Neoplasms, Hematologic Neoplasms

NCT02606994 2019-02-06

TPvsM

Phase 2 Terminated

1 enrolled

Other

Neoplasms, Stomatitis, Mucositis

NCT01017731 2015-06-10

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Phase 2 Completed

68 enrolled 13 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00887640 2014-02-26

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Phase 2 Terminated

11 enrolled 9 charts

Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

Clinical Trials

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Allogeneic Transplantation From Related Haploidentical Donors

TPvsM

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer